- Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis
-
Kamat N, Vuyyuru SK, Kedia S, Sahu P, Kante B, Kumar P, Ranjan MK, Singh MK, Kumar S, Sachdev V, Makharia G, Ahuja V
- KMID: 2529573
- Intest Res.
- 2022 Apr;20(2):269-273.
- doi: 10.5217/ir.2021.00064
-
- CITED
-
- Close
- SHARE
-
- Close
- Robotic-assisted right hepatectomy via anterior approach for intrahepatic cholangiocarcinoma
-
Goja S, Singh MK, Chaudhary , Soin AS
- KMID: 2379105
- Ann Hepatobiliary Pancreat Surg.
- 2017 May;21(2):80-83.
- doi: 10.14701/ahbps.2017.21.2.80
Major hepatic resection, especially right hepatectomy, has been successfully performed by specialized hepatobiliary centers using the robotic platform with low morbidity, conversion rates and outcomes comparable to laparoscopic and open... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatocellular carcinoma with atrial tumor thrombus presenting as myxoma: Resection under cardiopulmonary bypass
-
Singh MK, Roy R, Shetty V, Goja S
- KMID: 2508862
- Ann Hepatobiliary Pancreat Surg.
- 2020 Nov;24(4):518-521.
- doi: 10.14701/ahbps.2020.24.4.518
Surgical resection for Hepatocellular carcinoma (HCC) with atrial tumor thrombus is a rare life saving procedure. A case of left lateral segment liver tumor (HCC) with atrial tumor thrombus resected... -
- CITED
-
- Close
- SHARE
-
- Close
- Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas
-
Sachdeva K, Kumar P, Kante B, Vuyyuru SK, Mohta S, Ranjan MK, Singh MK, Verma M, Makharia G, Kedia S, Ahuja V
- KMID: 2541895
- Intest Res.
- 2023 Apr;21(2):226-234.
- doi: 10.5217/ir.2022.00010
Background/Aims: Intestinal tuberculosis (ITB) and Crohn’s disease (CD) frequently present with a diagnostic dilemma because of similar presentation. Interferon-gamma release assay (IGRA) has been used in differentiating ITB from CD,... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring
-
Kumar P, Vuyyuru SK, Das P, Kante B, Ranjan MK, Thomas DM, Mundhra S, Sahu P, Venigalla PM, Jain S, Goyal S, Golla R, Virmani S, Singh MK, Sachdeva K, Sharma R, Dash NR, Makharia G, Kedia S, Ahuja V
- KMID: 2547196
- Intest Res.
- 2023 Oct;21(4):460-470.
- doi: 10.5217/ir.2022.00128
Background/Aims: Evidence on predictors of primary nonresponse (PNR), and secondary loss of response (SLR) to anti-tumor necrosis factor (anti-TNF) agents in inflammatory bowel disease is scarce from Asia. We evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
